Fulgent Genetics, Inc. FLGT Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal)?
- Fulgent Genetics, Inc. (FLGT) reported accounts receivable, credit loss expense (reversal) of $1.19M in Q1 2026.
- How has Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
- Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal) decreased by 42.7% year-over-year, from $2.08M to $1.19M.
- What is the long-term trend for Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal)?
- Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s accounts receivable, credit loss expense (reversal) has grown at a -7.5% compound annual growth rate (CAGR), from $8.94M to $7.65M.